Related Concept Videos
01:23Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:28Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:19Electrophysiology of Normal Cardiac Rhythm
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
01:30Cardiac Action Potential
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
[Pathophysiology of pacing in patients with atrial fibrillation].
Herzschrittmachertherapie & Elektrophysiologie·2014
Related Experiment Video
Updated: Jun 22, 2026
09:47
A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
Published on: April 26, 2015
[Mechanisms of electrical defibrillation].
1Otto-von-Guericke-Universität Magdeburg Klinik für Kardiologie, Angiologie, Pneumologie im Zentrum Innere Medizin, 39120 Magdeburg.
Herzschrittmachertherapie & Elektrophysiologie
|June 5, 2009
Summary
Understanding ventricular fibrillation (VF) and defibrillation is crucial for developing better treatments. This study explores shock mechanisms and hypotheses, including the "upper limit of vulnerability," to improve defibrillation efficacy.
Area of Science:
- Cardiology
- Biophysics
- Electrophysiology
Context:
- Ventricular fibrillation (VF) is a life-threatening arrhythmia characterized by chaotic electrical activity in the ventricles.
- Electrical defibrillation is the primary treatment for VF, necessitating effective shock delivery without myocardial damage.
- The development of implantable cardioverter-defibrillators (ICDs) has spurred research into optimizing defibrillation waveforms and electrode configurations.
Purpose:
- To elucidate the fundamental mechanisms underlying successful cardiac defibrillation.
- To review and discuss various hypotheses explaining defibrillation, including the "upper limit of vulnerability" theory.
- To explore the potential advantages of biphasic shock waveforms over monophasic waveforms in defibrillation.
Summary:
- Defibrillation requires a shock of sufficient strength to terminate VF but not so strong as to cause myocardial injury.
- Cardiac cells respond to electrical shocks differently based on their action potential phase, leading to direct activation, graded response (prolonged refractoriness), or no effect.
- Successful defibrillation hinges on prolonging the refractory period in critical areas to prevent re-excitation, with a minimum potential gradient of 5-7 V/cm often required for monophasic shocks.
Impact:
- Advances in mapping systems, optical recording, microelectrodes, and mathematical modeling have significantly enhanced our understanding of defibrillation.
- The "upper limit of vulnerability" hypothesis provides a framework for understanding how shocks can terminate VF by preventing re-entrant wave formation.
- Biphasic waveforms show promise for lower defibrillation thresholds compared to monophasic shocks, warranting further investigation into their underlying mechanisms.